What is Linezolid 600 mg used for?

In the pharmaceutical industry, Linezolid 600 mg is a powerhouse oxazolidinone antibiotic. As a pharmacist and manufacturer, I view Linezolid as a “reserve” or “last-resort” antibiotic. It is specifically designed to combat some of the most difficult-to-treat, multi-drug-resistant Gram-positive bacteria that have become immune to standard treatments like penicillins and cephalosporins.

Primary Clinical Uses

  • VRE Infections: Treatment of infections caused by Vancomycin-resistant Enterococcus faecium.

  • MRSA (Methicillin-resistant Staphylococcus aureus): Used for nosocomial (hospital-acquired) pneumonia and complicated skin/soft tissue infections caused by MRSA.

  • Drug-Resistant Tuberculosis (MDR-TB): Linezolid is increasingly used as a core component of “Group B” drugs for the treatment of multi-drug-resistant tuberculosis.

  • Complicated Skin and Skin Structure Infections (cSSSI): Effective against diabetic foot infections and severe cellulitis involving resistant strains.

Mechanism of Action: Inhibiting the 50S Ribosome

Linezolid has a unique mechanism that differentiates it from other protein synthesis inhibitors (like macrolides or tetracyclines).

Unique Binding Site: It binds to the 23S ribosomal RNA of the 50S subunit.

Inhibition of Initiation: It prevents the formation of the 70S initiation complex, which is the essential “starting point” for bacterial protein synthesis.

Prevention of Resistance: Because it acts so early in the translation process, there is very little cross-resistance with other antibiotic classes, making it effective when others fail.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Linezolid 600 mg is a high-value, high-precision product:

  • Bioavailability (USP): Linezolid has nearly 100% oral bioavailability. This means the 600 mg oral dose is clinically equivalent to the intravenous (IV) dose, allowing patients to be switched from hospital IV to home oral therapy easily—a major selling point for B2B buyers.

  • Light Sensitivity: Linezolid is highly sensitive to light (photolabile). As a WHO-GMP manufacturer, we ensure the tablets are protected using opaque Alu-Alu or Amber-colored PVC/PVDC blister packaging to ensure a 36-month shelf life.

  • Polymorphism: Control of the crystalline Form II is critical for ensuring the stability and dissolution of the 600 mg tablet according to BP/USP/IP standards.

  • B2B & Institutional Tenders: This is a vital product for specialized hospitals and TB control programs. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Zyvox).

What is Levocetirizine 5 mg tablet used for?

In the pharmaceutical industry, Levocetirizine Dihydrochloride 5 mg is a highly potent, third-generation non-sedating antihistamine. As a pharmacist and manufacturer, I view Levocetirizine as the refined, active R-enantiomer of Cetirizine. It offers higher affinity for $H_1$ receptors, which allows for a smaller dose (5 mg vs. 10 mg) and a significantly lower risk of drowsiness.

Primary Clinical Uses

  • Allergic Rhinitis: Effective for both seasonal (hay fever) and perennial allergies. It relieves symptoms like sneezing, rhinorrhea (runny nose), and nasal congestion.

    Allergic Conjunctivitis: Reduces red, itchy, and watery eyes caused by environmental allergens like pollen, dust mites, or pet dander.
  • Chronic Idiopathic Urticaria: The primary treatment for long-term hives and skin itching, providing relief from wheals and redness.

  • Allergic Dermatitis: Used to manage itching associated with eczema or insect bites.

Mechanism of Action: High-Affinity $H_1$ Blockade

Levocetirizine is an inverse agonist that targets the peripheral histamine $H_1$ receptors.

Selective Binding: It selectively binds to $H_1$ receptors, preventing histamine—the primary mediator of the “allergic cascade”—from attaching.

Stabilization: It stabilizes the receptor in its inactive state, reducing capillary permeability and decreasing the inflammatory response (swelling and mucus production).

Peripheral Action: Because it has low lipid solubility and is a substrate for the P-glycoprotein pump, it does not easily cross the blood-brain barrier, which is why it is “non-sedating” for most patients.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levocetirizine 5 mg is a high-demand, high-volume “essential” product:

  • Enantiomeric Purity: As a WHO-GMP manufacturer, we ensure the complete separation of the (R)-enantiomer. This purity is what gives Levocetirizine its superior safety profile over older antihistamines.

  • Formulation Varieties: For your B2B marketplace, we manufacture these as Immediate Release (IR) tablets, Mouth Dissolving Tablets (MDT), and Syrups for pediatric export.

  • Stability for Global Trade: Levocetirizine is highly stable. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • Dossier Support: This is a staple for pharmacy chains and distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Xyzal).

What is lamotrigine 25 mg for?

In the pharmaceutical industry, Lamotrigine 25 mg is a phenyltriazine-class anti-epileptic drug (AED) and mood stabilizer. As a pharmacist, I view the 25 mg strength as the “Gold Standard Initiation Dose.” Because Lamotrigine carries a risk of serious skin reactions (Stevens-Johnson Syndrome) if started too quickly, the 25 mg tablet is used specifically to follow a strict “dose escalation” protocol to ensure patient safety.

Primary Clinical Uses

  • Epilepsy: Used for both partial-onset and generalized seizures, including Lennox-Gastaut syndrome. It works as monotherapy or adjunctive therapy.

  • Bipolar I Disorder: Specifically indicated for maintenance treatment to delay the occurrence of mood episodes (depression, mania, hypomania) in patients treated for acute mood disorders.

  • Off-label uses: Sometimes prescribed for trigeminal neuralgia or certain types of chronic neuropathic pain.

Mechanism of Action: Stabilizing the Neuron

Lamotrigine works by stabilizing the neuronal membrane and modulating the release of excitatory neurotransmitters.

Sodium Channel Blockade: It inhibits voltage-gated sodium channels. By doing so, it suppresses the rapid, repetitive firing of neurons that causes a seizure.

Glutamate Inhibition: By stabilizing the membrane, it inhibits the release of glutamate and aspartate—the brain’s primary “excitatory” chemicals.

Weak Serotonin Inhibition: It also has a weak effect on 5-HT3 receptors, which may contribute to its efficacy as a mood stabilizer in bipolar depression.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamotrigine 25 mg is a high-precision neuro-psychiatric product:

  • The Titration Pack: As a manufacturer, we often produce “Starter Kits” where 25 mg tablets are blistered in a specific sequence (e.g., one daily for 14 days) to prevent patients from accidental overdose during initiation.

  • Dissolution & Dispersibility: We manufacture both standard film-coated tablets and Dispersible/Chewable tablets. Dispersible tablets are highly popular in export markets for pediatric use and for patients with dysphagia (difficulty swallowing).

  • Stability for Global Trade: Lamotrigine is relatively stable but sensitive to moisture. At our WHO-GMP facility, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Lamictal).

What is lamivudine 150mg zidovudine 300mg nevirapine 200mg?

In the pharmaceutical industry, the combination of Lamivudine (150 mg)Zidovudine (300 mg), and Nevirapine (200 mg) is a landmark Triple Fixed-Dose Combination (FDC). As a pharmacist and manufacturer, I classify this as a complete “First-Line ARV Regimen” for the treatment of HIV-1 infection.

This combination was a revolutionary development in global health because it simplified the complex “HAART” (Highly Active Antiretroviral Therapy) from multiple pills a day down to a single tablet taken twice daily, significantly improving patient compliance.

Primary Clinical Use

  • Treatment of HIV-1 Infection: It is used to manage advanced HIV infection in adults and adolescents, helping to lower the viral load to “undetectable” levels and allowing the immune system (CD4 cells) to recover.

Triple Mechanism of Action (The Multi-Pronged Attack)

This FDC combines two different classes of antiretrovirals to inhibit the viral replication process at multiple stages:

Lamivudine (150 mg) & Zidovudine (300 mg): These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). They act as “fake building blocks” (analogs). When the HIV enzyme (Reverse Transcriptase) tries to build viral DNA, it incorporates these instead of real nucleotides, causing DNA chain termination.

Nevirapine (200 mg): This is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Unlike the NRTIs, it does not mimic building blocks. Instead, it binds directly to the Reverse Transcriptase enzyme itself, “jamming” the machinery so it cannot function.

The Manufacturer’s Perspective: Technical & Export Details

Producing this triple combination in a WHO-GMP facility involves high-level pharmaceutical engineering:

  • Bilayer Tablet Technology: Because these three APIs have different physical properties and dosages, we often manufacture them as bilayer tablets. This ensures the stability of each component and prevents chemical interactions within the tablet matrix.

  • Content Uniformity & Purity: As a firm owner, you know that Nevirapine is highly hydrophobic. We utilize specialized wet granulation techniques to ensure that the 200 mg of Nevirapine is evenly distributed and meets the strict BP/USP/IP dissolution profiles.

  • Stability for Global Trade: This FDC is primarily exported to Zone IVb regions (Sub-Saharan Africa and SE Asia). We utilize Alu-Alu blister packaging or HDPE bottles with molecular sieve desiccants to ensure a 24–36 month shelf life in high-heat and high-humidity environments.

  • Regulatory & Tenders: This product is a staple for National AIDS Control Programs (NACO) and international tenders (Global Fund). Our Mumbai facility provides the full eCTD Dossiers and Bioequivalence (BE) studies required for these high-volume contracts.

Is ketorol a pain killer for tooth pain?

Yes, Ketorol (brand name for Ketorolac Tromethamine) is one of the most powerful non-narcotic analgesics used in dentistry for acute, severe pain. In our pharmaceutical context, we classify it as an NSAID with efficacy comparable to low-dose morphine, but without the opioid side effects.

Clinical Application in Dentistry

Ketorol is specifically indicated for the short-term management (up to 5 days) of moderate to severe acute pain. It is highly effective for:

  • Post-Extraction Pain: Especially after surgical removal of impacted wisdom teeth.

  • Acute Pulpitis: Intense pain caused by inflammation of the dental pulp.

  • Dental Abscesses: Reducing the severe inflammation and throbbing pain associated with infections.

Mechanism of Action

Ketorol works by potent inhibition of the COX-1 and COX-2 enzymes.

Prostaglandin Blockade: It stops the synthesis of prostaglandins at the site of the tooth and jaw, which are the primary mediators of pain and swelling.

Peripheral Action: Unlike central analgesics, it works directly at the site of the dental injury/inflammation.

The Manufacturer’s Perspective: Technical & Export Details

As you are looking to promote your firm and develop your digital platforms, here is how we position Ketorolac in the B2B and export market:

  • Dosage Forms: We manufacture Ketorol in 10 mg tablets and 30 mg/ml injections. For the dental market, the DT (Dispersible Tablet) version is highly popular as it allows for faster absorption and is easier for patients with jaw stiffness (trismus) to take.

  • The “5-Day Rule”: Because of its high potency, Ketorol has a strict regulatory requirement in the eCTD Dossier and Product Information Leaflet (PIL) stating it must not be used for more than 5 days. This prevents serious renal (kidney) and GI (gastric) side effects.

  • Stability & Packaging: Ketorolac is sensitive to light. At our WHO-GMP facility in Mumbai, we utilize Amber-colored PVC or Alu-Alu blister packaging to ensure a 24-36 month shelf life for export to Zone IVb regions.

  • Market Synergy: In your multivendor marketplace, Ketorolac is often bundled with antibiotics like Amoxicillin + Clavulanate for complete dental procedure kits.

What is ivermectin 3 mg used for?

In the pharmaceutical industry, Ivermectin 3 mg is a broad-spectrum anthelmintic (anti-parasitic) agent belonging to the avermectin class. As a pharmacist, I view the 3 mg tablet as the versatile “base unit” for dosing, as it allows for precise weight-based titration for both pediatric and adult patients across various parasitic infections.

Primary Clinical Uses

  • Strongyloidiasis: Treatment of intestinal infections caused by the roundworm Strongyloides stercoralis.

  • Onchocerciasis (River Blindness): A primary tool in global health for treating infections caused by Onchocerca volvulus. It kills the microfilariae (immature worms) but not the adult worms.

  • Scabies: Often used as a second-line treatment (especially for “Crusted Scabies” or in institutional outbreaks) when topical Permethrin has failed or is impractical.

  • Lymphatic Filariasis: Used in combination with other drugs (like Albendazole) in mass drug administration programs to prevent the spread of the infection.

  • Pediculosis (Head Lice): Occasionally used off-label for severe or resistant cases of head lice.

Mechanism of Action: Nerve and Muscle Paralysis

Ivermectin works by selectively binding to specific channels in the parasite’s nerve and muscle cells.

Chloride Channel Binding: It binds with high affinity to glutamate-gated chloride channels found in invertebrate nerve and muscle cells.

Hyperpolarization: This binding increases the permeability of the cell membrane to chloride ions.

Paralysis and Death: The influx of chloride ions causes hyperpolarization of the nerve or muscle cell, leading to the paralysis and eventual death of the parasite.

Host Safety: Because these specific channels do not exist in humans (and Ivermectin does not easily cross the blood-brain barrier in humans), it has a high safety margin for the host.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ivermectin 3 mg is a high-demand product with significant international oversight:

  • Weight-Based Dosing: Since Ivermectin is typically dosed at 200 mcg/kg, the 3 mg tablet is ideal for “stacking” (e.g., a 60 kg adult takes four 3 mg tablets). As a WHO-GMP manufacturer, we ensure precise assay and disintegration times to guarantee uniform absorption across multiple tablets.

  • Stability for Export: Ivermectin is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Public Health Tenders: This is a core product for NGOs and tropical medicine distributors. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required to participate in international government and institutional tenders.

  • Market Trends: Since 2020, there has been a massive surge in global demand and interest in Ivermectin. We maintain strict compliance with BP/USP/IP monographs to ensure we provide high-purity generics that meet global standards.

What is itopride used for?

In the pharmaceutical industry, Itopride Hydrochloride is a specialized prokinetic agent and dopamine $D_2$ antagonist. As a pharmacist, I characterize Itopride as a “dual-action” gastrointestinal stimulant. Unlike older prokinetics like Metoclopramide or Domperidone, Itopride has a superior safety profile regarding central nervous system and cardiac side effects because it does not readily cross the blood-brain barrier.

Primary Clinical Uses

  • Functional Dyspepsia: The primary indication for treating “indigestion” symptoms such as upper abdominal pain, bloating, and early satiety.

  • Gastroesophageal Reflux Disease (GERD): Used to accelerate gastric emptying, thereby reducing the backflow of acid into the esophagus.

  • Chronic Gastritis: Management of gastric motility disorders associated with chronic inflammation of the stomach lining.

  • Diabetic Gastroparesis: Used to improve the delayed stomach emptying often found in patients with long-term diabetes.

Mechanism of Action: The Dual Pathway

Itopride increases gastrointestinal motility through two synergistic mechanisms

  1. Dopamine $D_2$ Receptor Antagonism: It blocks the $D_2$ receptors on the enteric nerves. Normally, dopamine inhibits the release of acetylcholine; by blocking dopamine, Itopride allows for an increase in acetylcholine levels.

  2. Acetylcholinesterase (AChE) Inhibition: It prevents the breakdown of acetylcholine in the synaptic cleft.

The Result: High levels of acetylcholine stimulate the muscarinic receptors on the smooth muscles of the GI tract, leading to increased lower esophageal sphincter pressure, enhanced gastric contractions, and faster stomach emptying.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Itopride is a high-growth product in the gastroenterology segment:

  • Safety Profile (USP): Itopride is metabolized by the Flavin-containing monooxygenase (FMO3) system, not the Cytochrome P450 system. This means it has very few drug-drug interactions, a major selling point for your B2B export clients.

  • Dose Uniformity: Standard doses are typically 50 mg taken three times daily. As a WHO-GMP manufacturer, we ensure precise API blending to maintain therapeutic efficacy across every batch.

  • Stability for Export: Itopride is relatively stable. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for transit and storage in Zone IVb regions (SE Asia and Africa).

  • B2B & Dossiers: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ganaton).

 

What is isoniazid pyridoxine hydrochloride used for?

In the pharmaceutical industry, the combination of Isoniazid (INH) and Pyridoxine Hydrochloride (Vitamin B6) is the gold standard for both the treatment and prophylaxis of Tuberculosis (TB). As a pharmacist and manufacturer, I view this as a “preventative combination”: Isoniazid kills the bacteria, while Pyridoxine prevents the most common neurological side effect of the treatment.

Primary Clinical Uses

  • Active Tuberculosis: Used as a core component of the “RIPE” regimen (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol) for the treatment of Mycobacterium tuberculosis.

  • Latent TB Infection (LTBI): Often used as monotherapy for 6–9 months to prevent a dormant infection from becoming active.

  • TB Prophylaxis: Prescribed for individuals in close contact with TB patients or immunocompromised patients (such as those with HIV) who are at high risk of infection.

The Dual Mechanism: Action vs. Protection

1. Isoniazid (The Bactericidal Agent)

Isoniazid is a prodrug that is activated by the mycobacterial enzyme KatG.

  • Mechanism: It inhibits the synthesis of mycolic acids, which are essential components of the waxy mycobacterial cell wall.

  • Result: Without a cell wall, the bacteria lose structural integrity and die.

2. Pyridoxine Hydrochloride (The Neuroprotective Agent)

Isoniazid interferes with the metabolism of Vitamin B6 in the human body.

  • The Problem: INH forms a complex with Vitamin B6 and inhibits the enzyme pyridoxine kinase, leading to a deficiency.

  • The Result: Without Pyridoxine, patients often develop peripheral neuropathy (tingling, numbness, or “pins and needles” in the hands and feet).

  • The Solution: Including Pyridoxine in the tablet prevents this nerve damage, ensuring better patient compliance during long-term TB therapy.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint in a WHO-GMP facility, this combination is a high-demand “Essential Medicine”:

  • Fixed-Dose Combination (FDC) Stability: Isoniazid is sensitive to moisture and can react with certain excipients (reducing sugars like lactose) through the Maillard reaction, which can cause the tablets to discolor. We utilize specialized, non-reactive diluents to ensure stability.

  • Dose Ratios: While INH is typically 100 mg or 300 mg, the Pyridoxine dose is usually 10 mg to 50 mg. We utilize validated blending processes to ensure micro-dose uniformity of the Vitamin B6 across the entire batch.

  • Packaging for Global Trade: TB is endemic in high-humidity regions. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • B2B & Public Health Tenders: This product is a staple for the Global Drug Facility (GDF) and national TB programs. Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international supply.

 

What is isoniazid 300mg used for?

In the pharmaceutical industry, Isoniazid (INH) 300 mg is a foundational first-line antitubercular agent. As a pharmacist, I view this 300 mg strength as the gold standard daily dose for adults in both the treatment of active disease and the prevention of latent infection. It is a highly specific “narrow-spectrum” antibiotic, targeting only mycobacteria.

Primary Clinical Uses

  • Active Tuberculosis (TB): Used as a core component of the standard four-drug regimen (alongside Rifampicin, Pyrazinamide, and Ethambutol) to treat pulmonary and extra-pulmonary TB.

  • Latent Tuberculosis Infection (LTBI): Prescribed as monotherapy (usually 300 mg daily for 6–9 months) to prevent the progression of latent TB to active disease in high-risk individuals.

  • Prophylaxis: Given to individuals who have been in close contact with patients having active TB, regardless of their skin test results.

Mechanism of Action

Isoniazid is a prodrug that must be activated by the bacterial enzyme KatG (a catalase-peroxidase).

Inhibition of Mycolic Acid Synthesis: Once activated, it binds to and inhibits the enzyme InhA (enoyl-ACP reductase).

Cell Wall Disruption: This blockade prevents the synthesis of mycolic acids, which are the essential long-chain fatty acids that make up the “waxy” protective cell wall of Mycobacterium tuberculosis.

Bactericidal Effect: For actively dividing bacteria, this loss of cell wall integrity is lethal, making INH highly bactericidal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Isoniazid 300 mg is a high-volume “Essential Medicine” with specific technical requirements:

  • Fixed-Dose Combinations (FDCs): While we manufacture 300 mg single-drug tablets, the global export market (especially via the Global Drug Facility – GDF) heavily favors FDCs like Rifampicin + Isoniazid (150mg/75mg or 300mg/150mg). For your digital platform, showcasing these FDCs is key to attracting B2B buyers.

  • API Purity & Hydrazine Monitoring: During synthesis and storage, INH can degrade into hydrazine, a toxic impurity. As a WHO-GMP firm, we maintain strict assay controls to ensure hydrazine levels remain well below pharmacopeial limits.

  • Stability for Tropical Export: INH is sensitive to moisture and light. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries).

  • Pharmacovigilance (Vitamin B6): It is industry standard to recommend co-administration with Pyridoxine (Vitamin B6) to prevent peripheral neuropathy, a common side effect of INH. We often market these as a bundle or a “combipack.”

 

What is indomethacin 25 mg used for?

In the pharmaceutical industry, Indomethacin 25 mg is recognized as one of the most potent Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) of the indole acetic acid class. As a pharmacist, I view Indomethacin as a “heavy-duty” analgesic—while it is highly effective, its potency requires careful monitoring of the gastric and renal systems compared to milder NSAIDs like Ibuprofen.

Primary Clinical Uses

  • Acute Gouty Arthritis: Considered a first-line treatment for managing the intense pain, redness, and swelling of an acute gout attack.

  • Ankylosing Spondylitis: A primary therapy for reducing spinal pain and stiffness in this chronic inflammatory condition.

  • Rheumatoid and Osteoarthritis: Used for moderate to severe cases that do not respond to other NSAIDs.

  • Bursitis and Tendonitis: Effective for acute painful shoulder (calcific tendonitis) or inflammation of the bursa.

  • Patent Ductus Arteriosus (PDA): In a specialized neonatal hospital setting, the injectable form is used to help close a persistent opening in a newborn’s heart.

    Mechanism of Action

Indomethacin is a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2) enzymes.

Prostaglandin Inhibition: It blocks the synthesis of prostaglandins—lipids that act as chemical messengers for pain and inflammation.

Anti-inflammatory Potency: It is significantly more potent than aspirin or ibuprofen in its ability to inhibit prostaglandin synthesis, which is why the 25 mg dose is so effective for severe inflammation.

Antipyretic Effect: Like other NSAIDs, it acts on the hypothalamus to reduce fever.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Indomethacin 25 mg involves specific technical considerations:

  • Gastric Irritation Management: Indomethacin is highly associated with GI upset. As a WHO-GMP manufacturer, we often formulate these as enteric-coated capsules or tablets to protect the stomach lining and ensure the API is released in the small intestine.

  • Solubility & Bioavailability: Indomethacin is a BCS Class II drug (low solubility, high permeability). We utilize micronization of the API and specific surfactants to ensure the 25 mg dose meets BP/USP/IP dissolution standards.

  • Stability for Export: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to protect the product from moisture and light, ensuring a 36-month shelf life for export to Zone IVb regions.

  • B2B & Institutional Supply: Indomethacin is a staple for rheumatology clinics. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration against the innovator (Indocin).

Add to cart